✨ Medicines Distribution Consent
4356 NEW ZEALAND GAZETTE No. 166
Manufacturer(s):
Mentholatum Australasia Pty Limited, Scoresby, Victoria, Australia
Product:
Losec IV
Active Ingredient(s):
Omeprazole sodium 42.6mg equivalent to 40mg Omeprazole
Dosage Form:
Powder for infusion
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer(s):
AstraZeneca AB, Södertälje, Sweden
Product:
Onectyl
Active Ingredient(s):
Vinorelbine tartrate 13.85mg/mL equivalent to 10mg/mL vinorelbine
Dosage Form:
Solution for injection
New Zealand Sponsor:
Asta Medica Australasia Pty Limited
Manufacturer(s):
Pierre Fabre Medicament Production, Etablissement Aquitaine Pharm International, Idron, France
Dated this 6th day of December 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
g99181
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Aropax
Active Ingredient(s):
Paroxetine hydrochloride 24.9mg equiv to 20mg Paroxetine
Dosage Form:
Film coated tablet
New Zealand Sponsor:
SmithKline Beecham (NZ) Limited
Manufacturer(s):
Les Laboratoires Beecham, Mayenne, France
SmithKline Beecham Pharmaceuticals Limited, Magpie Wood, Manor Royal, Crawley, Sussex, England
Product:
Foradil
Active Ingredient(s):
Eformoterol fumarate 12µg
Dosage Form:
Powder filled inhalation capsule
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Novartis Pharma Stein AG/SA, Stein, Switzerland
Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom
Product:
Fosamax
Active Ingredient(s):
Alendronate sodium 13.05mg equivalent to 10mg Alendronic acid
Dosage Form:
Tablet
New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s):
Merck Manufacturing Division of Merck and Co., Bo. Sabana Hoyos, Arecibo, Puerto Rico
Merck Sharp & Dohme SpA., Pavia, Italy
Product:
Fosamax
Active Ingredient(s):
Alendronate sodium 6.53mg equivalent to 5mg alendronic acid
Dosage Form:
Tablet
New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s):
Merck Sharp & Dohme SpA., Pavia, Italy
Product:
Ultravist 240
Active Ingredient(s):
Iopromide 498.72mg/mL equivalent to 240mg iodine
Dosage Form:
Solution for injection
New Zealand Sponsor:
Schering (NZ) Limited
Manufacturer(s):
Schering AG, Wedding Plant, Berlin, Germany
Dated this 6th day of December 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2000, No 166
Gazette.govt.nz —
NZ Gazette 2000, No 166
✨ LLM interpretation of page content
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare6 December 2000
Medicines Act 1981, New Medicine, Losec IV, Onectyl, Omeprazole, Vinorelbine
- G. R. BOYD, Chief Advisor, Safety and Regulation
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social Welfare6 December 2000
Medicines Act 1981, Changed Medicine, Aropax, Foradil, Fosamax, Ultravist 240, Paroxetine, Eformoterol, Alendronate, Iopromide
- G. R. BOYD, Chief Advisor, Safety and Regulation